Upper Respiratory Tract Sarcoidosis
ICD-10 D86.8 ICD-11 4B20.Y.2

First-Line Treatment of Upper Respiratory Tract Sarcoidosis

Upper respiratory tract sarcoidosis requires systemic treatment when the disease is active or progressive. A structured first-line approach is used to reduce inflammation, slow disease progression, and prevent organ damage.

Treatment Approach
First-line management involves oral corticosteroid therapy, administered according to a defined initial course with a planned taper over subsequent months. The complete dosing schedule, tapering protocol, and clinical decision points are in the full structured regimen below.
Instant Access to Structured Evidence-Based Regimens
References

Corticosteroid medications are considered the first line of treatment for sarcoidosis that requires therapy.

Oral corticosteroids effectively reduce systemic inflammation in most people, thereby slowing, stopping or even preventing organ damage.

After 3-6 months, the dose should be tapered to physiologic levels – for example, 10 mg of prednisone per day or less.

View source ↗